SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001549595-24-000031
Filing Date
2024-02-15
Accepted
2024-02-15 16:51:56
Documents
5
Effectiveness Date
2024-02-15
Reference 429
333-269671

Document Format Files

Seq Description Document Type Size
1 S-8 nrix-20240215xs8_evergreen.htm S-8 75117
2 EX-FILING FEES nrix-20240215xs8_ex107.htm EX-FILING FEES 24475
3 EX-5.1 nrix-20240215xs8_ex51fw.htm EX-5.1 13573
4 EX-23.1 nrix-20240215xs8_ex231pwc.htm EX-23.1 2024
5 image_0a.jpg GRAPHIC 17663
  Complete submission text file 0001549595-24-000031.txt   140822
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: S-8 | Act: 33 | File No.: 333-277114 | Film No.: 24644557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)